B Grosman, N Parikh, A Roy, L Lintereur… - Annals of Biomedical …, 2023 - Springer
In silico simulation studies using 5807 virtual patients with insulin dependent diabetes have been conducted to estimate the risk and efficacy with the closed-loop 780G pump when …
D Dutta, R Mohindra, K Mahajan… - … & Metabolism Journal, 2023 - synapse.koreamed.org
Background No meta-analysis has analysed efficacy and safety of fast-acting aspart insulin (FIAsp) with insulin pump in type 1 diabetes mellitus (T1DM). Methods Electronic databases …
Background: Computer simulators of human metabolism are powerful tools to design and validate new diabetes treatments. However, these platforms are often limited in the diversity …
LR Brown - Drug Discovery and Evaluation: Safety and …, 2024 - Springer
The use of biomaterials to enable and enhance life-saving therapies in medicine has its documented roots in the 1600s. Historically drugs were administered systemically for acute …
Insulin has been utilized in the treatment of type 1 diabetes (T1D) for 100 years. While there is still no cure for T1D, insulin administration has undergone a remarkable evolution which …
Control affine assumptions, human inputs are external disturbances, in certified safe controller synthesis approaches are frequently violated in operational deployment under …
L Meyer - Médecine des Maladies Métaboliques, 2024 - Elsevier
Résumé Ces dernières années, plusieurs analogues ultra-rapides de l'insuline ont été développés afin de réduire la durée d'absorption sous-cutanée de l'insuline et améliorer …
T Danne, L Heinemann, J Bolinder - Diabetes Technology & …, 2022 - liebertpub.com
Background Insulin icodec is a novel basal insulin analog intended for once‐weekly administration. The aim of this phase 2 trial was to investigate the efficacy and safety of …
Высокая вариабельность гликемии (ВГ) оказывает значительное влияние на прогрессирование осложнений у больных сахарным диабетом (СД). В ходе работы при …